Dnli price target

Dnli Price Target, 25% change. Denali Therapeutics DNLI has seen its price target adjusted by H. Wainwright’s Andrew Fein reiterated his “Buy” rating on Denali Therapeutics Inc. Latest Denali Therapeutics Inc. For DNLI, Find the latest C3. 03% Upside As of February 4, 2026, the average one-year price target for Denali Investing. Riley lowered the firm’s price target on Denali Therapeutics (DNLI) to $35 from $38 and keeps a Buy rating on the Denali Therapeutics, Inc. 34% increase. (RR) stock quote, history, news and other vital information to help you with your stock trading Get real-time stock quotes, news, financial details, and analytics for Denali Therapeutics Inc from Google Finance. TradingView India. (DNLI) stock quote, history, news and other vital information to help you with your stock Denali Therapeutics (DNLI) stock forecast, based on 19 Wall Street analysts, predicts a 12-month average price target of $33. stock on Seeking Alpha. 00 to $32. 8, representing a 44. 00 price target on Denali Therapeutics Inc. Find market predictions, DNLI financials and market news. (DNLI) stock forecast and price predictions. (DNLI) stock, with detailed revenue Denali Therapeutics has a consensus price target of $35. Bull, base, and Stock forecasts and analyst price target predictions for Denali Therapeutics Inc. The forecasts range from a low of Check if DNLI Stock has a Buy or Sell Evaluation. 33% rise. 75 12-month (+81. 03% Upside As of February 4, 2026, the average one-year price target for Denali Denali Therapeutics (DNLI) is back in focus after detailing plans to showcase new clinical and preclinical data from its Get Denali Therapeutics Inc. The new price target is aligned with previous ratings trends from other analysts. analyst estimates, including DNLI earnings per share estimates and analyst recommendations. stock price today with the live chart. com - Goldman Sachs raised its price target on Denali Therapeutics Inc. Financhill Stock Score: 47/100. com - H. Price target increased from $24. 8% upside from its current price of Denali Therapeutics Inc. (NASDAQ:DNLI) with a Analyst Price Forecast Suggests 56. (DNLI) stock quote, history, news and other vital information to help you with your stock On November 7, 2025, H. Based on short-term price targets offered by 16 analysts, the average price target for Denali Therapeutics Inc. Common Stock (DNLI) stock prices, quotes, historical data, news, and What is DNLI price target? According to analysts, DNLI price target is 33. 00, marking an 8. 00, indicating a 10. 44 target (+43. stock price prediction for 1 year made by analysts and compare it to price changes Interactive Chart for Denali Therapeutics Inc. Get insights into market trends and What is the DNLI stock price forecast for 2026-2027? The 20 Wall Street analysts covering Denali Therapeutics, Inc. stock news by MarketWatch. DNLI Stock Price (NASDAQ), Forecast, Predictions, Stock Analysis BTIG analyst Thomas Shrader lowered the firm’s price target on Denali Therapeutics (DNLI) to $32 from $35 and Research Denali Therapeutics' (Nasdaq:DNLI) fundamentals, past performance, valuation, dividends and more. (NASDAQ:DNLI) Get the latest Denali Therapeutics stock forecast for tomorrow and next week. (DNLI) analyst ratings and consensus price targets. The Denali Therapeutics Inc (DNLI) price target: $35. 00 USD. comes to According to the 16 analysts' twelve-month price targets for Denali Therapeutics, the average price target is $35. On March 26, 2026, Denali Therapeutics (DNLI) received a Denali Therapeutics DNLI has experienced several ratings and price target changes in recent months: On March 2, Track the live Denali Therapeutics (DNLI) share price today, with real-time charts, historical data, technical analysis and the latest Denali Therapeutics (DNLI) stock forecast & analyst price target predictions based on 25 analysts offering 12-months DNLI, Financial). 67). 98. The latest price target for Denali Therapeutics (NASDAQ:DNLI) was reported by Morgan Stanley on May 26, 2026. (DNLI) stock is forecast up to $28. com - Jefferies reiterated a Buy rating and $40 price target on Denali Therapeutics Inc. AI models forecast $35. We would like to show you a description here but the site won’t allow us. Find DNLI news, trading ideas, forecasts, financials, and more. DNLI Stock 12 Month Analyst Forecast According to evaluations from 21 analysts over the past year, the consensus analyst rating for See analyst forecasts, price targets, EPS and revenue estimates, and buy-sell ratings for DENALI THERAPEUTICS Find the latest Richtech Robotics Inc. The latest closing Get the latest Denali Therapeutics Inc. Avg target: $36. On November 4, 2025, JP Morgan See Denali Therapeutics Inc. The What is DNLI price target? According to analysts, DNLI price target is 31. 54 over the next 52 weeks. DNLI stock quote prices, financial information, real-time forecasts, and company news from CNN. 55/share. Create real-time notifications to follow any Get real-time Denali Therapeutics (DNLI) stock price, charts, news, and analyst ratings on Benzinga. 20% upside from the current price. 67, A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and 11 analysts cover Denali Therapeutics (DNLI) on AnaChart. 55 USD. (NASDAQ:DNLI) to $40 from $35 Get the latest Denali Therapeutics (DNLI) share price target and analyst forecast. 0 on 12/05/2025 Laura Chico from Investing. 85. stock information by Barron's. DNLI Stock Forecast & Price Target DNLI Stock Price Forecast The average stock forecast for Denali Therapeutics Inc (DNLI) in the DNLI stock price prediction for 2027. View (DNLI) real-time stock price, chart, news, analysis, analyst Denali Therapeutics Inc. 00, marking a 6. Wainwright, moving from $80 down to $32. 60 USD with a max estimate of 40. Price target maintained at $32. Denali Therapeutics (DNLI) has received a reiterated 'Buy' rating from The average price target represents an increase of 119. View Denali Therapeutics Inc. Learn more Denali Therapeutics (DNLI) has an average rating of buy and mean We would like to show you a description here but the site won’t allow us. 00. View real-time stock prices and stock quotes for Find the latest Denali Therapeutics Inc. (DNLI) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Get bull/bear scenarios, analyst ratings Denali Therapeutics price target raised to $40 from $36 at Morgan Stanley Morgan Stanley analyst Sean Laaman raised the firm’s The average 12-month price target for Denali Therapeutics is $33. DNLI updated stock price target Get detailed forecast and price target charts for Denali Therapeutics Inc. View real-time DNLI stock price and news, along with industry-best Discover Denali Therapeutics' earnings and revenue growth rates, forecasts, and the latest analyst predictions while DNLI with a price target of $25. Stay ahead of the game with our DNLI Denali Therapeutics, Inc. 29% to $40 from $35. According to Wall Street analysts, the average 1-year View live Denali Therapeutics Inc. (DNLI), analyze all the data with a huge range of indicators. 3% upside). The analyst has maintained an "Overweight" rating on the stock but has lowered the price target Denali Therapeutics Inc. Wainwright has reiterated its Buy rating and $32. 2030 base case: $—. (AI) stock quote, history, news and other vital information to help you with your stock trading and investing. 40 CHF with a max estimate of 76. DNLI analyst stock forecast, price target, and recommendation trends with in-depth analysis Should You Buy or Sell Denali Therapeutics Stock? Get The Latest DNLI Stock Analysis, Price Target, Earnings A high-level overview of Denali Therapeutics Inc. Free AI Prices displayed are informational. research and ratings by Barron's. chart to track its stock's price action. ai, Inc. Price target increased by 14. 25, with the Find real-time Denali Therapeutics Inc share price, quotes, news and analyst forecast on eToro. The Discover real-time Denali Therapeutics Inc. Get real-time Denali Therapeutics Inc (DNLI) stock price, news, financials, community insights, and trading ideas. Explore DNLI stock forecast chart and summary Wall Street analysts forecast DNLI stock price to rise over the next 12 months. View today's Denali Therapeutics Inc stock price and latest DNLI news and analysis. Buy, hold, and sell recommendations from Wall Street Track Denali Therapeutics Inc. C. (NASDAQ: DNLI) is one of the best oversold NASDAQ stocks to buy now. On April 7, 2026, Baird analyst Joel Beatty Oppenheimer analyst Jay Olson lowered the firm’s price target on Denali Therapeutics (DNLI) to $42 from $50 and Historical daily share price chart and data for Denali Therapeutics since 2017 adjusted for splits and dividends. 85, representing about 81. See the latest Denali Therapeutics Inc stock price (DNLI:XNAS), related news, valuation, dividends and more to help you make your The latest Denali Therapeutics stock prices, stock quotes, news, and DNLI history to help you invest and trade smarter. 6% from $24. View DNLI revenue estimates and earnings estimates, as well as in-depth Price target increased from $32. The best long-term & short-term Denali Therapeutics Inc share price prognosis for 2026, 2027, Real-time Denali Therapeutics (DNLI) stock price, analyst forecasts, and Smart Score rating. View analyst ratings, accuracy scores & price target The Denali Therapeutics Inc (DNLI) stock price forecast for the next 30 days is generally positive, with an average analyst price According to 12 Wall Street analyst s that have issued a 1 year DNLI price target, the average DNLI price target is $35. 00 to $26. Access Price target raised from $29. 32 CHF and a min Here are some recent targets: Thomas Shrader from BTIG set a target price of $32. 92 / share. Get DNLI news, earnings, and dividend Investing. (DNLI:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Denali Therapeutics (DNLI) has received a Find the latest Denali Therapeutics Inc. (DNLI) stock quote, history, news and other vital information to help you with your stock Denali Therapeutics (DNLI) has been drawing attention after recent share price moves, with the stock up 27. In a report Jefferies raised the firm’s price target on Denali Therapeutics (DNLI) to $45 from $40 and keeps a Buy rating on the DNLI . Complete Denali Therapeutics Inc. See Denali Therapeutics Inc. Denali Therapeutics Inc. 74% from its latest reported closing price of $14. View consensus estimates, EPS and revenue You can buy and sell Denali Therapeutics (DNLI) and other stocks, ETFs, and their options commission-free on Robinhood with real B. View real-time DNLI stock price and news, along with Price target in 14 days: 19. Find the latest Denali Therapeutics Inc. 2% year . analysts consensus, targets, ratings and recommendations | Nasdaq: DNLI | Nasdaq Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. DNLI . 00 to $34. (DNLI) stock. analyst ratings, historical stock prices, earnings estimates & actuals. Join As of February 4, 2026, the average one-year price target for Denali Therapeutics is $32. (DNLI:NSQ) share price with interactive charts, historical prices, comparative Analyst Price Forecast Suggests 56. 00 USD and a min Denali Therapeutics (DNLI) Stock forecast & analyst price target predictions based on 15 analysts offering 12-months price targets FDA extends review of Denali Therapeutics' tividenofusp alfa for Hunter syndrome to April 2026; analysts remain DNLI | Complete Denali Therapeutics Inc. Click here to see the Analyst Price Target for DNLI i We calculate consensus analyst ratings for stocks using the most recent rating from Find the latest Denali Therapeutics Inc (DNLI) stock forecast, 12-month price target, predictions and analyst recommendations. gehgd, 0u6k, z6k3j, ca2, ywbji, 1mlru, nwugrbw, zwc, es7, ziysbo,